The Release of Catecholamines from Adrenergic Neurons

Author: Paton   David M.  

Publisher: Elsevier Science‎

Publication year: 2013

E-ISBN: 9781483188119

P-ISBN(Paperback): 9780080215365

P-ISBN(Hardback):  9780080215365

Subject: Q42 nerve physiology

Language: ENG

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Description

The Release of Catecholamines from Adrenergic Neurons covers the advances in understanding the mechanism of catecholamine release and other neurotransmitters from adrenergic neurons. This book is organized into four sections encompassing 18 chapters.

The opening section surveys biochemical studies of the mechanism and regulation of nerve stimulation. This section examines the role of calcium, prostaglandins, and presynaptic adrenoceptors and muscarine receptors in catecholamine release. The next section describes the modification of catecholamine release by several drugs, including adrenergic neuron blocking agents, narcotic analgesics, opioid peptides, lysergic acid diethylamide, anesthetics, alcohols, and adenosine and adenine nucleotides. These topics are followed by discussions of catecholamine release induced by cations and other drugs, such as nicotinic agonists, calcium ionophores, veratridine, scorption venom, and phenethylamines. The final section deals with the biochemical assessment of peripheral adrenergic activity and the clinical pharmacology of adrenergic neuron blocking agents.

This book is intended for pharmacologists, neurologists, researchers, and advanced students.

Chapter

Front Cover

pp.:  1 – 4

Copyright Page

pp.:  5 – 8

Table of Contents

pp.:  8 – 10

LIST OF CONTRIBUTORS

pp.:  10 – 12

PREFACE

pp.:  12 – 14

CHAPTER 2. ULTRASTRUCTURAL STUDIES OF THE MECHANISM OF RELEASE

pp.:  30 – 52

CHAPTER 3. THE ROLE OF CALCIUM IN CATECHOLAMINE RELEASE FROM ADRENERGIC NERVE TERMINALS

pp.:  52 – 72

CHAPTER 4. PRESYNAPTIC ADRENOCEPTORS AND REGULATION OF RELEASE

pp.:  72 – 100

CHAPTER 5. PRESYNAPTIC MUSCARINE RECEPTORS AND INHIBITION OF RELEASE

pp.:  100 – 124

CHAPTER 6. ROLE OF PROSTAGLANDINS AND CYCLIC ADENOSINE MONOPHATE IN RELEASE

pp.:  124 – 156

CHAPTER 7. PRESYNAPTIC REGULATION OF RELEASE IN THE CENTRAL NERVOUS SYSTEM

pp.:  156 – 198

CHAPTER 8. MODIFICATION OF RELEASE BY ADRENERGIC NEURON BLOCKING AGENTS AND AGENTS THAT ALTER THE ACTION POTENTIAL

pp.:  198 – 230

CHAPTER 9. MODIFICATION OF CATECHOLAMINE RELEASE BY NARCOTIC ANALGESICS AND OPIOID PEPTIDES

pp.:  230 – 242

CHAPTER 10. MODIFICATION OF RELEASE BY LYSERGIC ACID DIETHYLAMIDE

pp.:  242 – 254

CHAPTER 11. MODIFICATION OF CATECHOLAMINE RELEASE BY ANAESTHETICS AND ALCOHOLS

pp.:  254 – 276

CHAPTER 12. MODIFICATION OF RELEASE BY ADENOSINE AND ADENINE NUCLEOTIDES

pp.:  276 – 288

CHAPTER 13. RELEASE INDUCED BY NICOTONIC AGONISTS

pp.:  288 – 316

CHAPTER 14. RELEASE INDUCED BY CALCIUM IONOPHORES

pp.:  316 – 336

CHAPTER 15. RELEASE INDUCED BY ALTERATIONS IN EXTRACELLULAR POTASSIUM AND SODIUM AND BY VERATRIDINE AND SCORPION VENOM

pp.:  336 – 346

CHAPTER 16. RELEASE INDUCED BY PHENETHYLAMINES

pp.:  346 – 368

CHAPTER 17. BIOCHEMICAL ASSESSMENT OF PERIPHERAL ADRENERGIC ACTIVITY

pp.:  368 – 386

CHAPTER 18. THE CLINICAL PHARMACOLOGY OF ADRENERGIC NEURON BLOCKING AGENTS

pp.:  386 – 394

INDEX

pp.:  394 – 407

The users who browse this book also browse